Continuous glucose monitors (CGMs), insulin pumps and insulin pump consumables: Procurement status
Find the latest information on Pharmac’s procurement process for continuous glucose monitoring (CGM) devices, insulin pumps and insulin pump consumables.
Thank you for your feedback to the consultation
We received a significant amount of feedback on our proposal, which reflects how important these devices are to people living with type 1 diabetes, their whānau, and clinicians. Thank you for sharing your views and experiences with us.
We have identified aspects of the proposal that we need to consider further. This means that the timeframe for making CGMs available, if approved by the Pharmac Board, will be pushed back.
At this point we can’t provide a definitive timeframe for when a decision will be made. We are working on this as a priority to enable a decision to be made as soon as possible. Pharmac is committed to progressing this proposal.
More information about this update is available on the following pages:
Media release: Pharmac considering feedback on diabetes CGMs funding proposal
Online information session – Thursday 6 June 2024
Pharmac will host an online information session to talk about the process of developing the funding proposal and provide an update on Pharmac’s next steps, including engagement with clinicians, consumers and suppliers.
Details of information session:
- 12 noon until 12.45pm, Thursday 6 June
- Session will be online on Teams – attendees will not need an account to join
- The session will be recorded and available on Pharmac’s website afterwards
Next update
We understand people would like to know more as soon as possible. This page will be updated on Friday 7 June 2024.
Timing of the procurement process
Pharmac initially signalled interest in funding CGMs and considering the supply of insulin pumps and insulin pump consumables in February 2023.
We understand people would like to know how long this procurement process will take. Below we have noted the milestones we have worked to so far.
Unfortunately, the time required to undertake procurement processes can vary. As such, we can’t be certain about future timings. However, we will share updates on this webpage as more information becomes available.
Milestone | Date |
---|---|
FPO release | Complete (February 2023) |
Clinical advice | Complete (April 2023) |
Publishing records of clinical advice from the diabetes Specialist Advisory Committee | Complete (July 2023) |
RFP release | Complete (July 2023) |
Supplier briefing | Complete (July 2023) |
Stakeholder briefing | Complete (August 2023) |
Bids close | Complete (August 2023) |
Evaluation committee meetings and seeking further clinical advice | Complete (November 2023) |
Contracting with preferred suppliers | Complete (March 2024) |
Consultation period | Complete (April 2024) |
Pharmac Board meeting | To be confirmed |
Decision notification date | To be confirmed |
Provisional implementation date | To be confirmed |
The funding process
We had previously received funding applications for Dexcom, FreeStyle Libre and Medtronic CGMs. Applications Pharmac received prior to this process:
We received bids from a number of suppliers in response to the Request for Proposals (RFP) for the supply of CGMs, insulin pumps and insulin pump consumables. To assess these bids, we held three evaluation committee meetings, including clinical experts, consumer representatives, and Pharmac staff. Pharmac uses information gathered during the evaluation meetings, alongside the Factors for Consideration, to select the preferred suppliers.
Who to contact
We will update this page as more information becomes available.
If your question is not answered here, email enquiry@pharmac.govt.nz